Moller Financial Services Amgen Inc Transaction History

Moller Financial Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 19, 2021	SELL	$221.91 - $258.6 $1.48 Million - $1.72 Million	-6,653 Closed	0 $0
Q4 2020 Jan 11, 2021	BUY	$216.38 - $257.67 $1.44 Million - $1.71 Million	6,653 New	6,653 $1.53 Million
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $1.48 Million - $1.67 Million	-8,172 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$178.4 - $208.25 $1.46 Million - $1.7 Million	8,172 New	8,172 $1.61 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Moller Financial Services, based on Form 13F filings with the SEC.

Stay updated on Moller Financial Services with notifications on news.